医学信息
醫學信息
의학신식
MEDICAL INFORMATION
2013年
22期
122-123
,共2页
低分子肝素%不稳定型心绞痛
低分子肝素%不穩定型心絞痛
저분자간소%불은정형심교통
Low molecular weight heparin%Unstable angina pectoris
稳定型心绞痛(UAP)是冠心病中仅次于透壁性心肌梗死的综合征，临床治疗及预后较差。低分子肝素治疗UAP疗效显著，对改善预后有重要临床意义。常规治疗基础上+低分子肝素皮下注射+口服小剂量阿司匹林。低分子肝素+阿司匹林治疗UAP后，心绞痛发作频率减少，间隔时间延长，心电图及动态心电图心肌缺血明显改善。
穩定型心絞痛(UAP)是冠心病中僅次于透壁性心肌梗死的綜閤徵，臨床治療及預後較差。低分子肝素治療UAP療效顯著，對改善預後有重要臨床意義。常規治療基礎上+低分子肝素皮下註射+口服小劑量阿司匹林。低分子肝素+阿司匹林治療UAP後，心絞痛髮作頻率減少，間隔時間延長，心電圖及動態心電圖心肌缺血明顯改善。
은정형심교통(UAP)시관심병중부차우투벽성심기경사적종합정，림상치료급예후교차。저분자간소치료UAP료효현저，대개선예후유중요림상의의。상규치료기출상+저분자간소피하주사+구복소제량아사필림。저분자간소+아사필림치료UAP후，심교통발작빈솔감소，간격시간연장，심전도급동태심전도심기결혈명현개선。
Objective: unstable angina pectoris (UAP) is a syndrome of coronary heart disease after transmural myocardial infarction, clinical treatment and prognosis is poor. Ef ect of low molecular weight heparin in treatment of UAP significantly, which has important clinical significance for improving the prognosis of. Methods: on the basis of conventional therapy plus low molecular weight heparin subcutaneous injection and oral administration of low-dose aspirin. Results:low molecular weight heparin plus aspirin in the treatment of UAP, frequency of angina pectoris at ack reduced, prolong the interval of electrocardiogram and dynamic electrocardiogram, myocardial ischemia significantly improved.
